Evidence map›Paper›PMID 41018708›Full record

ArticleOpen forum infectious diseases2025

Comparative Outcomes Following

Armaghan-E-Rehman Mansoor, Gayathri Krishnan, Julio C Zuniga-Moya, Benjamin Papadopoulus, Andrej Spec, Ige George

Abstract read
In one paragraph

Article in Open forum infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Armaghan-E-Rehman MansoorDivision of Infectious Diseases, Department of Internal Medicine, University of Kentucky, Lexington, Kentucky, United States.ORCID https://orcid.org/0000-0002-2087-187X
Gayathri KrishnanDivision of Infectious Diseases, Department of Medicine, Washington University in St. Louis, St. Louis, Missouri, United States.
Julio C Zuniga-MoyaDivision of Infectious Diseases, Department of Medicine, Washington University in St. Louis, St. Louis, Missouri, United States.ORCID https://orcid.org/0000-0002-8561-5463
Benjamin PapadopoulusDivision of Infectious Diseases, Department of Medicine, Washington University in St. Louis, St. Louis, Missouri, United States.
Andrej SpecDivision of Infectious Diseases, Department of Medicine, Washington University in St. Louis, St. Louis, Missouri, United States.ORCID https://orcid.org/0000-0001-7612-4710
Ige GeorgeDivision of Infectious Diseases, Department of Medicine, Washington University in St. Louis, St. Louis, Missouri, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Candida bloodstream infections (BSI) carry a high risk of adverse outcomes. Left ventricular assist devices (LVADs) are increasingly used to manage end-stage heart failure; however, they carry a risk of infection. This study evaluates the impact of LVAD presence on outcomes in patients with Methods: A total of 1233 patients with Results: Patients with Conclusions: In patients with

Indexed as

bloodstream infectionCandidemiaLeft ventricular assist deviceLVADMCS

Identifiers

PMID41018708
PMCPMC12461839

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.